SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-032264
Filing Date
2022-11-14
Accepted
2022-11-14 17:15:42
Documents
12
Period of Report
2022-11-14
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 82861
  Complete submission text file 0001493152-22-032264.txt   260716

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE mtnb-20221114.xsd EX-101.SCH 3251
3 XBRL LABEL FILE mtnb-20221114_lab.xml EX-101.LAB 34916
4 XBRL PRESENTATION FILE mtnb-20221114_pre.xml EX-101.PRE 22805
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3800
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-484-8805
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38022 | Film No.: 221387640
SIC: 2834 Pharmaceutical Preparations